071401Unexpected Priority: Stem Cell Research's Rise as a Test for Bush
       
             
            July 14, 2001
            NEWS ANALYSIS
            Unexpected Priority: Stem Cell Research's Rise as a Test for Bush
            By FRANK BRUNI
            ASHINGTON, July 13 — The debate about research on embryonic stem 
            cells has traveled in just a month's time from relative obscurity to 
            magazine-cover ubiquity, and, many political analysts and lawmakers 
            say it has become a defining issue of President Bush's first year in 
            office.
            With social conservatives imploring Mr. Bush to withhold federal 
            support for the research and moderates pushing him to permit it, he 
            faces a decision that could fix his place on the political spectrum 
            more firmly than anything he has done to date.
            Both Republicans and Democrats said that for many voters, the course 
            Mr. Bush charts would be interpreted as a indicator of the extent to 
            which he feels bound to the right or, alternately, is willing to 
            reach toward the center.
            During a period when some polls have shown a drop in Mr. Bush's 
            approval ratings and he could use more support from moderates than 
            he seems to have, his decision could shape voters' attitudes toward 
            him in crucial ways, analysts said.
            Embryonic stem cells have the potential to grow into any cell or 
            tissue, holding promise for repairing and replacing damaged organs. 
            The research draws opposition from religious conservatives, as well 
            as the Roman Catholic Church, because it results in the destruction 
            of embryos. 
            The issue's potency is reflected in the months of meetings that Mr. 
            Bush has devoted to it and the frequency with which it pops up in 
            conversations around the West Wing. Several White House officials 
            said that stem cell research has provoked as much formal and casual 
            discussion as anything since Mr. Bush's inauguration nearly six 
            months ago.
            Several lawmakers characterized the issue as something of a litmus 
            test for Mr. Bush.
            "It's an opportunity for him, having fully established his 
            conservative credentials, to establish compassionate credentials," 
            said Senator Susan Collins, a Maine Republican who supports the 
            research.
            Ms. Collins said the issue was also an opportunity for Mr. Bush "to 
            show a degree of independence" from social conservatives in his 
            party.
            John Weaver, a senior political aide to Senator John McCain, 
            Republican of Arizona, said that the way Mr. Bush acted on this 
            issue, along with his handling of a patients' bill of rights, could 
            speak powerfully to "a perception, and I'm not saying it's fair, 
            that this administration is too tied to corporate interests and very 
            conservative."
            Mr. Weaver added that Mr. Bush's actions could "lock some of those 
            perceptions down permanently among voters or, if the administration 
            goes in a different direction, could soften those perceptions."
            Administration officials have said that Mr. Bush will most likely 
            make a decision on the research financing before the end of July. If 
            he withholds or severely restricts federal support, the decision may 
            be seen as more ideological than, say, his ban on federal funds for 
            overseas groups that provide abortion-related counseling, because 
            many abortion opponents support the stem-cell research.
            "We're into new territory here," one senior administration official 
            said. "It doesn't slice nice."
            This official and others said the issue was complicated enough — and 
            stirred enough passion — that the only sure benefit Mr. Bush could 
            wring from his decision was a public perception that he reached it 
            thoughtfully.
            To that end, the White House press secretary, Ari Fleischer, has 
            repeatedly said that Mr. Bush was listening to every viewpoint and 
            taking a deeply "deliberative" approach.
            Mr. Bush has received contradictory political analyses. Some 
            prominent Republicans contend that a permissive decision on the 
            research will not be enough to win over moderates, so he would be 
            wisest to stay with his conservative base. According to this 
            thinking, only conservatives can be trusted to reward him.
            Other Republicans who advise the administration see serious 
            political danger for Mr. Bush, at this particular juncture, if he 
            reinforces the most socially conservative aspects of his image.
            "If he goes and refuses to use stem-cell research — if he bans it — 
            then I think he will look more rigid and inflexible than he wants 
            to," said one Republican strategist who often speaks with 
            administration officials.
            Another administration adviser said: "It's a defining issue. If the 
            administration can find a middle ground, they can really move 
            people's impressions of him as a very conservative president."
            Several people familiar with the White House deliberations said Mr. 
            Bush might not feel completely tethered to a campaign position of 
            seemingly unwavering opposition to the research.
            Conversely, some administration officials are studying scientific 
            arguments against the research, apparently in the hope of justifying 
            a ban on the research along those lines.
            The argument would be that similarly controversial research on fetal 
            tissue has not yielded measurable progress and that doctors are 
            intrigued by the promise of stem cells derived from body fat that do 
            not involve the destruction of embryos.
            There have been no clear hints of what Mr. Bush will decide.
            David Gergen, a longtime political strategist who has worked in both 
            Republican and Democratic administrations, said the president's 
            prolonged contemplation of the issue suggested he was moving beyond 
            his thinking during the campaign.
            "Why would he delay otherwise?" Mr. Gergen asked. "Why would he go 
            through this process that is only raising the political price of any 
            decision? I don't think the public was paying much attention to it 
            just three to four weeks ago."
            Polls generally show much more public support than opposition to 
            federal funding of the research, but they also suggest that people 
            are still sifting through their feelings — and can be swayed one way 
            or the other. Partly for that reason, some political analysts 
            contend that Mr. Bush can safely make any decision he likes, as long 
            as he articulates it well.
            "The president has a great deal of flexibility," said Bill 
            McInturff, a Republican pollster. Mr. McInturff added that by his 
            reading of current polls, "I don't see any evidence that he's been 
            pushed beyond a comfortable center-right majority of this country."
            On his tax cut and education plan, Mr. Bush has indeed attracted 
            significant Democratic support. But he has alienated many moderate 
            voters with his positions and actions on environmental issues.
            "Swing voters are moving away from him," said Doug Schoen, a 
            Democratic pollster. "So this is the time when he really has to make 
            key decisions." Foremost among them, Mr. Schoen said, was federal 
            support for embryonic stem cells research.
            Little more than a month ago, the public interest in it was minimal.
            "Now it's an avalanche," said Senator Arlen Specter, a Pennsylvania 
            Republican who supports the research. "It's just overwhelming."
   
            Copyright 2001 The New York Times Company | Privacy Information